Financial reports
10-K/A
2023 FY
Annual report (amended)
26 Apr 24
10-K
2023 FY
Annual report
1 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
7 Mar 22
Current reports
8-K
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
25 Apr 24
8-K
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
18 Mar 24
8-K
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
8-K/A
Financial Statements and Exhibits
19 Jan 24
8-K
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
8 Jan 24
8-K
Standard BioTools Stockholders Approve Merger with SomaLogic
5 Jan 24
8-K
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
29 Dec 23
8-K
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
22 Dec 23
8-K
Investor Presentation Unlocking Value in a Fragmented Space DECEMBER 2023
19 Dec 23
8-K
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
4 Dec 23
Registration and prospectus
S-3/A
Shelf registration (amended)
2 Feb 24
S-3
Shelf registration
19 Jan 24
S-3
Shelf registration
19 Jan 24
S-8
Registration of securities for employees
19 Jan 24
S-8
Registration of securities for employees
19 Jan 24
425
Business combination disclosure
29 Dec 23
425
Business combination disclosure
22 Dec 23
424B3
Prospectus supplement
21 Dec 23
425
Business combination disclosure
19 Dec 23
425
Business combination disclosure
4 Dec 23
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFR14A
Revised proxy
29 Mar 22
DEFR14A
Revised proxy
28 Mar 22
DEFA14A
Additional proxy soliciting materials
22 Mar 22
DEFA14A
Additional proxy soliciting materials
21 Mar 22
DEFA14A
Additional proxy soliciting materials
18 Mar 22
DEFA14A
Additional proxy soliciting materials
14 Mar 22
Other
EFFECT
Notice of effectiveness
8 Feb 24
EFFECT
Notice of effectiveness
8 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
EFFECT
Notice of effectiveness
4 Dec 23
CORRESP
Correspondence with SEC
1 Dec 23
UPLOAD
Letter from SEC
27 Nov 23
CORRESP
Correspondence with SEC
13 Nov 23
Ownership
4
Michael Egholm
9 Apr 24
4
Michael Egholm
5 Apr 24
4
Hanjoon Alex Kim
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
SC 13G/A
VIKING GLOBAL INVESTORS LP
20 Mar 24
3
OLE ANDREAS HALVORSEN
20 Mar 24
4
Eli Casdin
20 Mar 24
SC 13D/A
Casdin Capital, LLC
20 Mar 24
144
Notice of proposed sale of securities
19 Mar 24